Progenics Pharmaceuticals Inc (PGNX)

7.17
NASDAQ : Health Care
Prev Close 7.17
Day Low/High 0.00 / 0.00
52 Wk Low/High 4.60 / 11.72
Avg Volume 1.02M
Exchange NASDAQ
Shares Outstanding 70.27M
Market Cap 498.92M
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Oversold Small-Cap Biotech Names

Oversold Small-Cap Biotech Names

I am working incrementally into some small stocks with great long-term value.

3 Biotechs to Buy This Summer

3 Biotechs to Buy This Summer

These companies will do well, despite a range bound sector.

Interesting PGNX Put And Call Options For February 2018

Interesting PGNX Put And Call Options For February 2018

Investors in Progenics Pharmaceuticals, Inc. saw new options begin trading this week, for the February 2018 expiration.

Progenics Pharmaceuticals Announces The Presentation Of Data From Two Automated Bone Scan Index Studies At The 2017 ASCO Annual Meeting

Establishes Automated BSI as Prognostic Biomarker for Overall Survival

Progenics Pharmaceuticals Enters Oversold Territory (PGNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DMLP, GPL, HZN, LPSN Downgrades: AGLE, AKAM, ASFI, FOR, HTLD, LLY, NTZ, OSTK, PGNX, PWR, RECN, TRNC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Relative Strength Alert For Progenics Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Short Interest Expands By 13.2% For PGNX

The most recent short interest data has been released for the 04/13/2017 settlement date, which shows a 928,274 share increase in total short interest for Progenics Pharmaceuticals, Inc. , to 7,977,161, an increase of 13.17% since 03/31/2017.

PGNX Crosses Below Key Moving Average Level

In trading on Friday, shares of Progenics Pharmaceuticals, Inc. crossed below their 200 day moving average of $7.82, changing hands as low as $7.67 per share.

Short Interest Drops 23% For PGNX

The most recent short interest data has been released for the 03/31/2017 settlement date, which shows a 2,093,733 share decrease in total short interest for Progenics Pharmaceuticals, Inc. , to 7,048,887, a decrease of 22.90% since 03/15/2017.

What Poker Taught Me About Investing

What Poker Taught Me About Investing

I've learned that emotions have little use at a poker table; they don't in the stock market, either.

What Poker Taught Me About Investing

What Poker Taught Me About Investing

I've learned that emotions have little use at a poker table; they don't in the stock market, either.

First Week Of November 17th Options Trading For Progenics Pharmaceuticals (PGNX)

Investors in Progenics Pharmaceuticals, Inc. saw new options become available this week, for the November 17th expiration.

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.

Biotech Premarket Movers: Progenics, Alexion, BioCryst

Biotech Premarket Movers: Progenics, Alexion, BioCryst

Progenics, Alexion and BioCryst were among the biotech stock movers in premarket trading on Thursday.

TheStreet Quant Rating: D+ (Sell)